Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Steatohepatitic hepatocellular carcinoma, a morphologic indicator of associated metabolic risk factors: a study from India.

Jain D, Nayak NC, Kumaran V, Saigal S.

Arch Pathol Lab Med. 2013 Jul;137(7):961-6. doi: 10.5858/arpa.2012-0048-OA.

PMID:
23808468
2.

Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.

Salomao M, Yu WM, Brown RS Jr, Emond JC, Lefkowitch JH.

Am J Surg Pathol. 2010 Nov;34(11):1630-6. doi: 10.1097/PAS.0b013e3181f31caa.

PMID:
20975341
3.

Steatohepatitic variant of hepatocellular carcinoma in the absence of metabolic syndrome or background steatosis: a clinical, pathological, and genetic study.

Yeh MM, Liu Y, Torbenson M.

Hum Pathol. 2015 Nov;46(11):1769-75. doi: 10.1016/j.humpath.2015.07.018. Epub 2015 Aug 4.

PMID:
26410018
4.

Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study.

Alexander J, Torbenson M, Wu TT, Yeh MM.

J Gastroenterol Hepatol. 2013 May;28(5):848-54. doi: 10.1111/jgh.12116.

PMID:
23302015
5.

Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis?

Guzman G, Brunt EM, Petrovic LM, Chejfec G, Layden TJ, Cotler SJ.

Arch Pathol Lab Med. 2008 Nov;132(11):1761-6. doi: 10.1043/1543-2165-132.11.1761.

PMID:
18976012
6.

The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis.

Salomao M, Remotti H, Vaughan R, Siegel AB, Lefkowitch JH, Moreira RK.

Hum Pathol. 2012 May;43(5):737-46. doi: 10.1016/j.humpath.2011.07.005. Epub 2011 Oct 20.

PMID:
22018903
7.

Hepatocellular carcinoma with steatohepatitic features: a clinicopathological study of Japanese patients.

Shibahara J, Ando S, Sakamoto Y, Kokudo N, Fukayama M.

Histopathology. 2014 Jun;64(7):951-62. doi: 10.1111/his.12343. Epub 2014 Feb 5.

PMID:
24898917
8.

Hepatocellular carcinoma in nonalcoholic fatty liver cirrhosis and alcoholic cirrhosis: risk factor analysis in liver transplant recipients.

Jain D, Nayak NC, Saigal S.

Eur J Gastroenterol Hepatol. 2012 Jul;24(7):840-8. doi: 10.1097/MEG.0b013e3283534b40.

PMID:
22495397
9.

Tumor stroma with senescence-associated secretory phenotype in steatohepatitic hepatocellular carcinoma.

Lee JS, Yoo JE, Kim H, Rhee H, Koh MJ, Nahm JH, Choi JS, Lee KH, Park YN.

PLoS One. 2017 Mar 8;12(3):e0171922. doi: 10.1371/journal.pone.0171922. eCollection 2017.

10.

Influence of risk factors for metabolic syndrome and non-alcoholic fatty liver disease on the progression and prognosis of hepatocellular carcinoma.

Takamatsu S, Noguchi N, Kudoh A, Nakamura N, Kawamura T, Teramoto K, Igari T, Arii S.

Hepatogastroenterology. 2008 Mar-Apr;55(82-83):609-14.

PMID:
18613418
11.

Surgical treatment of hepatocellular carcinoma associated with the metabolic syndrome.

Cauchy F, Zalinski S, Dokmak S, Fuks D, Farges O, Castera L, Paradis V, Belghiti J.

Br J Surg. 2013 Jan;100(1):113-21. doi: 10.1002/bjs.8963. Epub 2012 Nov 12.

12.

HCC and NASH: how strong is the clinical demonstration?

Rosmorduc O, Fartoux L.

Clin Res Hepatol Gastroenterol. 2012 Jun;36(3):202-8. doi: 10.1016/j.clinre.2011.12.011. Epub 2012 Feb 10. Review.

PMID:
22326764
13.

Etiologic types of end-stage chronic liver disease in adults: analysis of prevalence and their temporal changes from a study on native liver explants.

Nayak NC, Jain D, Vasdev N, Gulwani H, Saigal S, Soin A.

Eur J Gastroenterol Hepatol. 2012 Oct;24(10):1199-208. doi: 10.1097/MEG.0b013e32835643f1.

PMID:
22751227
14.

Obesity and diabetes as a risk factor for hepatocellular carcinoma.

Regimbeau JM, Colombat M, Mognol P, Durand F, Abdalla E, Degott C, Degos F, Farges O, Belghiti J.

Liver Transpl. 2004 Feb;10(2 Suppl 1):S69-73.

15.

Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma.

Duan XY, Qiao L, Fan JG.

Hepatobiliary Pancreat Dis Int. 2012 Feb;11(1):18-27. Review.

PMID:
22251466
16.

Nonalcoholic fatty liver disease and the metabolic syndrome: clinical implications and treatment.

Rahimi RS, Landaverde C.

Nutr Clin Pract. 2013 Feb;28(1):40-51. doi: 10.1177/0884533612470464. Epub 2013 Jan 3. Review.

PMID:
23286927
17.

Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma.

Yasui K, Hashimoto E, Komorizono Y, Koike K, Arii S, Imai Y, Shima T, Kanbara Y, Saibara T, Mori T, Kawata S, Uto H, Takami S, Sumida Y, Takamura T, Kawanaka M, Okanoue T; Japan NASH Study Group, Ministry of Health, Labour, and Welfare of Japan.

Clin Gastroenterol Hepatol. 2011 May;9(5):428-33; quiz e50. doi: 10.1016/j.cgh.2011.01.023. Epub 2011 Feb 12.

PMID:
21320639
18.

Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma.

Kawamura Y, Arase Y, Ikeda K, Seko Y, Imai N, Hosaka T, Kobayashi M, Saitoh S, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Ohmoto Y, Amakawa K, Tsuji H, Kumada H.

Am J Gastroenterol. 2012 Feb;107(2):253-61. doi: 10.1038/ajg.2011.327. Epub 2011 Oct 18.

PMID:
22008893
19.

Non-alcoholic steatohepatitis and cancer.

Bugianesi E.

Clin Liver Dis. 2007 Feb;11(1):191-207, x-xi. Review.

PMID:
17544979

Supplemental Content

Support Center